أحد الأهداف الرئيسية لـ Life4me + - منع حالات الإصابة الجديدة بفيروس نقص المناعة البشرية والأمراض المنقولة جنسياً الأخرى والتهاب الكبد الوبائي والسل.

يساعد التطبيق على تأسيس اتصال مجهول بين الأطباء والمصابين بفيروس نقص المناعة البشرية. انها تسمح لك بسهولة تنظيم جدول الدواء الخاص بك وإعداد تذكير خفية وشخصية.

إلى الوراء
٣ مارس ٢٠١٧, ١٥:١٢
3088

New Research From West Africa Claims HIV-2’s Virulence May Has Been Underestimated.

New Research From West Africa Claims HIV-2’s Virulence May Has Been Underestimated. - صورة 1

HIV-2 is less easy to transmit, and typically viral loads in blood are one or two orders of magnitude lower than with HIV-1, at about 2500 copies/ml. However, the virus integrates into host DNA in the same amount as with HIV-1.

 

HIV-2 epidemiology reflects its animal origin - sooty mangabey monkeys that are a West African species with most wide spreading in Cape Verde, Guinea-Bissau, Sierra Leone, Gambia and also in Ivory Coast, Senegal, Nigeria and Mali.

 

Because HIV-2 is less virulent than HIV-1 and therefore less frequently transmitted, it has tended to be out-competed by HIV-1. Surveillance of HIV in pregnant women in Guinea-Bissau has shown that while HIV-1 prevalence was practically zero till the beginning of the 1990s, it had risen to 6% by 2008. In contrast, HIV-2 prevalence was 8% among 1987 and 1992 but decreased to 1% by 1008.

 

Researchers from the University of Oxford suggested that although progression to AIDS and death in HIV-2 infection was slower than with HIV-1, it was the rule rather than the exception, the estimates of progression of HIV-2 to AIDS and death had been underestimated. In his study, Professor Joakim Esbjörnsson looked at progression to AIDS and death among the Guinea-Bissau police cohort. Initiated in 1990, this includes 4820 members with HIV-1 and HIV-2, all police officers, 13% of them women.

 

The report of the study presented at last month's Conference on Retroviruses and Opportunistic Infections (CROI 2017) indicates that HIV-2 was nearly 90% lethal within 25 years of infection. The researchers explain this by that after 20 years of the initiation of the cohort, while 90% of people with HIV-1 had progressed to AIDS, so had 70% of their counterparts with HIV-2, showing that previous studies had considerably underestimated the mortality and morbidity due to HIV-2.

 

The research team concluded that it's necessary to pay more attention to epidemiological studies of HIV-2 and consider these novel findings in planning future research projects.

مشاركة على وسائل التواصل الاجتماعي